13 Feb 2023
$310.3 million for research to improve Australians' health, primary health care and research infrastructure
Medical Research Future Fund (MRFF) grant opportunities to the value of $310.3 million are now available
13 Feb 2023
$310.3 million for research to improve Australians' health, primary health care and research infrastructure
Medical Research Future Fund (MRFF) grant opportunities to the value of $310.3 million are now available
13 Feb 2023
$310.3 million for research to improve Australians' health, primary health care and research infrastructure
Medical Research Future Fund (MRFF) grant opportunities to the value of $310.3 million are now available
10 Feb 2023
The Big Picture: Helping our medical researchers turn discoveries into products to improve our health
It takes time and money to turn a scientific discovery into a medical product ready for use. To help medical researchers along this road, in 2017 the MRFF began funding medical research commercialisation. The Big Picture asks what impact our funds are having.
10 Feb 2023
The Big Picture: Helping our medical researchers turn discoveries into products to improve our health
It takes time and money to turn a scientific discovery into a medical product ready for use. To help medical researchers along this road, in 2017 the MRFF began funding medical research commercialisation. The Big Picture asks what impact our funds are having.
10 Feb 2023
The Big Picture: Helping our medical researchers turn discoveries into products to improve our health
It takes time and money to turn a scientific discovery into a medical product ready for use. To help medical researchers along this road, in 2017 the MRFF began funding medical research commercialisation. The Big Picture asks what impact our funds are having.
08 Feb 2023
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
08 Feb 2023
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
08 Feb 2023
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
08 Feb 2023
ATAGI 2023 booster advice
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.
